Cargando…

Survival outcomes and safety of carmustine wafers in the treatment of high-grade gliomas: a meta-analysis

Carmustine wafers (CW; Gliadel(®) wafers) are approved to treat newly-diagnosed high-grade glioma (HGG) and recurrent glioblastoma. Widespread use has been limited for several reasons, including concern that their use may preclude enrollment in subsequent clinical trials due to uncertainty about con...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chowdhary, Sajeel A., Ryken, Timothy, Newton, Herbert B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2015
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4368843/ https://www.ncbi.nlm.nih.gov/pubmed/25630625 http://dx.doi.org/10.1007/s11060-015-1724-2

Ejemplares similares

Adverse Event with the Use of Carmustine Wafers and Postoperative Radiochemotherapy for the Treatment of High-grade Glioma
por: Salle, Federico, et al.
Publicado: (2018)

Carmustine Wafers Implantation in Patients With Newly Diagnosed High Grade Glioma: Is It Still an Option?
por: Ricciardi, Luca, et al.
Publicado: (2022)

The Combination of Carmustine Wafers and Fotemustine in Recurrent Glioblastoma Patients: A Monoinstitutional Experience
por: Lombardi, Giuseppe, et al.
Publicado: (2014)

NICE guidance on the use of carmustine wafers in high grade gliomas: a national study on variation in practice
por: Price, Stephen J., et al.
Publicado: (2012)

Safety and efficacy of carmustine (BCNU) wafers for metastatic brain tumors
por: Ene, Chibawanye I., et al.
Publicado: (2016)

Carmustine Wafer Implantation at the Era of Standardized Chemoradiation Protocol
por: Roux, Alexandre, et al.
Publicado: (2019)

Cerebral Infarction Related to Carmustine Wafers in Glioblastoma: A Case Report
por: Nakada, Mitsutoshi, et al.
Publicado: (2014)

Early Postoperative Expansion of Parenchymal High-intensity Areas on T(2)-weighted Imaging Predicts Delayed Cerebral Edema Caused by Carmustine Wafer Implantation in Patients with High-grade Glioma
por: MASUDA, Yosuke, et al.
Publicado: (2015)

Polifeprosan 20, 3.85% carmustine slow-release wafer in malignant glioma: evidence for role in era of standard adjuvant temozolomide
por: Kleinberg, Lawrence
Publicado: (2012)

In vitro Study of Serial Changes to Carmustine Wafers (Gliadel) with MR Imaging and Computed Tomography
por: Doishita, Satoshi, et al.
Publicado: (2017)

Polifeprosan 20, 3.85% carmustine slow release wafer in malignant glioma: patient selection and perspectives on a low-burden therapy
por: Kleinberg, Lawrence
Publicado: (2016)

Identification of a Prognostic Microenvironment-Related Gene Signature in Glioblastoma Patients Treated with Carmustine Wafers
por: Manini, Ivana, et al.
Publicado: (2022)

Preservation of neurocognitive function and local control of 1 to 3 brain metastases treated with surgery and carmustine wafers
por: Brem, Steven, et al.
Publicado: (2013)

Double-edged Sword in the Placement of Carmustine (BCNU) Wafers along the Eloquent Area: A Case Report
por: Kuramitsu, Shunichiro, et al.
Publicado: (2014)

Symptomatic cerebral vasospasm in the setting of carmustine wafer placement for glioblastoma: A case presentation and review of literature
por: Khan, Maheen Qamar, et al.
Publicado: (2020)

Surgical Outcomes of High-Grade Spinal Cord Gliomas
por: Seki, Toshitaka, et al.
Publicado: (2015)

Early toxicity predicts long-term survival in high-grade glioma
por: Lawrence, Y R, et al.
Publicado: (2011)

The Clinical Frailty Scale as predictor of overall survival after resection of high-grade glioma
por: Klingenschmid, Julia, et al.
Publicado: (2022)

MPC-03 IMMUNOHISTOCHEMICAL ANALYSIS OF TUMOR ASSOCIATED MACROPHAGE INDUCED AFTER BIODEGRADABLE CARMUSTINE WAFER IMPLANTATION IN HUMAN GLIOBLASTOMA
por: Shibahara, Ichiyo, et al.
Publicado: (2019)

Glioblastoma fed by middle meningeal artery and displaying cyst formation soon after repeated implantation of carmustine wafers: A case report
por: Yamamuro, Shun, et al.
Publicado: (2017)

Secondary dissemination in children with high-grade malignant gliomas and diffuse intrinsic pontine gliomas
por: Wagner, S, et al.
Publicado: (2006)

Does early resection of presumed low-grade glioma improve survival? A clinical perspective
por: Wijnenga, Maarten M. J., et al.
Publicado: (2017)

Facing Contrast-Enhancing Gliomas: Perfusion MRI in Grade III and Grade IV Gliomas according to Tumor Area
por: Di Stefano, Anna Luisa, et al.
Publicado: (2014)

Long-term survival outcomes of pineal region gliomas
por: Choque-Velasquez, Joham, et al.
Publicado: (2020)

Global post-marketing safety surveillance of Tumor Treating Fields (TTFields) in patients with high-grade glioma in clinical practice
por: Shi, Wenyin, et al.
Publicado: (2020)

Chronic Phase Intracranial Hemorrhage Caused by Ruptured Pseudoaneurysm Induced by Carmustine Wafer Implantation for Insulo-opercular Anaplastic Astrocytoma: A Case Report
por: SATO, Kimitoshi, et al.
Publicado: (2015)

Is Interstitial Chemotherapy with Carmustine (BCNU) Wafers Effective against Local Recurrence of Glioblastoma? A Pharmacokinetic Study by Measurement of BCNU in the Tumor Resection Cavity
por: Ohnishi, Takanori, et al.
Publicado: (2022)

Second Surgery in Insular Low-Grade Gliomas
por: Ius, Tamara, et al.
Publicado: (2015)

Safety of second-line chemotherapy with non-conventional fotemustine schedule in recurrent high grade gliomas: a single institution experience
por: Gaviani, P., et al.
Publicado: (2013)

5-Aminolevulinic Acid Fluorescence in High Grade Glioma Surgery: Surgical Outcome, Intraoperative Findings, and Fluorescence Patterns
por: Puppa, Alessandro Della, et al.
Publicado: (2014)

Supportive care of patients diagnosed with high grade glioma and their carers in Australia
por: Halkett, Georgia K. B., et al.
Publicado: (2022)

Intraoperative Contrast Enhanced Ultrasound Evaluates the Grade of Glioma
por: Cheng, Ling-Gang, et al.
Publicado: (2016)

Cerebellar location may predict an unfavourable prognosis in paediatric high-grade glioma
por: Karremann, M, et al.
Publicado: (2013)

The effects of clinical and sociodemographic factors on survival, resource use and lead times in patients with high-grade gliomas: a population-based register study
por: Bergqvist, Jenny, et al.
Publicado: (2018)

Utility of Nuclear Morphometry in Predicting Grades of Diffusely Infiltrating Gliomas
por: Boruah, Dibyajyoti, et al.
Publicado: (2013)

Spatial distribution of malignant transformation in patients with low-grade glioma
por: Jakola, Asgeir S., et al.
Publicado: (2020)

Is the anatomical distribution of low-grade gliomas linked to regions of gliogenesis?
por: Skjulsvik, Anne Jarstein, et al.
Publicado: (2020)

Evidence for improved survival with bevacizumab treatment in recurrent high-grade gliomas: a retrospective study with (“pseudo-randomized”) treatment allocation by the health insurance provider
por: Hofmann, Susanne, et al.
Publicado: (2020)

Phase II trial of radiotherapy after hyperbaric oxygenation with chemotherapy for high-grade gliomas
por: Ogawa, K, et al.
Publicado: (2006)

Carmustine-Induced Phosphatidylserine Translocation in the Erythrocyte Membrane
por: Jilani, Kashif, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_jkhhqsv1km2qsro8hr3olikelk